ClearPoint Neuro provides MRI-guided navigation and delivery systems for neurosurgical and neurological procedures. Its platform enables real-time imaging during interventions such as deep brain stimulation electrode placement and targeted drug or gene therapy delivery into the brain. Hospitals and neurosurgical centers use the technology when precision trajectory planning under MRI is required.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 9.2 | — | -5.8 | — |
| Q3 2025 | 8.9 | — | -5.9 | — |
| Q4 2025 | 10.4 | — | -7.8 | — |
| Q1 2026 | 12.1 | — | -9.6 | — |
| Q2 2026 | 10.9 | 18.1% | -11.3 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: K&F Growth Acquisition Corp. II (KFIIU), NewHold Investment Corp IV (NHIV), Virginia National Bankshares Corporation (VABK), Surrozen, Inc. (SRZN), Alico, Inc. (ALCO), Archimedes Tech SPAC Partners II Co. (ATII)